Page last updated: 2024-08-25

we 201 and Coronary Artery Disease

we 201 has been researched along with Coronary Artery Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Daida, H; Dohi, T; Hayashi, N; Ikeda, H; Kishimoto, T; Kurano, M; Matsuyama, N; Miyauchi, K; Nagasaki, M; Nakamura, K; Nojiri, T; Ohkawa, R; Okubo, S; Sakai, N; Uno, K; Yatomi, Y; Yokota, H	1

Other Studies

1 other study(ies) available for we 201 and Coronary Artery Disease

Article	Year
Development of an enzymatic assay for sphingomyelin with rapid and automatable performances: Analysis in healthy subjects and coronary heart disease patients. Clinical biochemistry, 2012, Volume: 45, Issue:16-17 Topics: 1,2-Dipalmitoylphosphatidylcholine; Acute Coronary Syndrome; Analysis of Variance; Angina, Stable; Calibration; Case-Control Studies; Cholesterol, HDL; Cholesterol, LDL; Coronary Artery Disease; Enzyme Assays; Female; Humans; Limit of Detection; Lysophosphatidylcholines; Magnesium; Male; Reference Standards; Sphingomyelins	2012

Article

Year

Development of an enzymatic assay for sphingomyelin with rapid and automatable performances: Analysis in healthy subjects and coronary heart disease patients.

Clinical biochemistry, 2012, Volume: 45, Issue:16-17

Topics: 1,2-Dipalmitoylphosphatidylcholine; Acute Coronary Syndrome; Analysis of Variance; Angina, Stable; Calibration; Case-Control Studies; Cholesterol, HDL; Cholesterol, LDL; Coronary Artery Disease; Enzyme Assays; Female; Humans; Limit of Detection; Lysophosphatidylcholines; Magnesium; Male; Reference Standards; Sphingomyelins

2012